Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction
Cardiac Study. Cellular Cardiomyoplasty of Infarcted Failed Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
Sponsor: Azienda Unita Sanitaria Locale di Piacenza
A PHASE1/PHASE2 clinical study on Acute Myocardial Infarction, this trial is ongoing. The trial is conducted by Azienda Unita Sanitaria Locale di Piacenza and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Change History
6 versions recorded-
Dec 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Unita Sanitaria Locale di Piacenza
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Piacenza, Italy